What Is HIFU?

HIFU (High-Intensity Focused Ultrasound) is an incisionless, non-radiation treatment for prostate cancer. It uses precisely focused ultrasound waves — delivered through a probe placed in the rectum — to heat targeted prostate tissue to over 80 °C, instantly destroying the cancer cells.

Because the energy is focused like sunlight through a magnifying glass, only the targeted area is destroyed. The surrounding prostate, urethra, neurovascular bundles (responsible for erections), and rectum are spared.

Why Focal Therapy?

Traditional treatments — radical prostatectomy and whole-gland radiation — treat the entire prostate, even areas without cancer. HIFU lets us treat only the cancer, similar to how breast cancer can be treated with a lumpectomy rather than a mastectomy. The goal: control the cancer while preserving urinary continence and sexual function.

How HIFU Works

1. Mapping the Cancer

  • A high-quality multi-parametric MRI (mpMRI) identifies suspicious lesions
  • A targeted MRI-fusion biopsy confirms cancer location and grade
  • Imaging is fused with real-time ultrasound to create a precise 3D treatment plan

2. Treatment

  • Performed under general or spinal anesthesia
  • An ultrasound probe is placed in the rectum (no incisions)
  • The probe delivers many small focused-ultrasound "shots," each ablating a precise volume of prostate tissue
  • Real-time imaging lets your surgeon shape the treatment around urethra, sphincter, and nerves
  • Procedure typically takes 1–3 hours

Treatment Patterns

  • Focal HIFU — treats only the lesion plus a small margin (most common)
  • Hemiablation — treats one lobe of the prostate when cancer is unilateral
  • Whole-gland HIFU — used in selected cases (e.g., recurrence after radiation)

Typical Visit

  • Outpatient procedure
  • 1–3 hours of treatment time
  • Foley catheter for ~1–2 weeks
  • Most patients go home the same day

Who Is a Candidate?

Ideal Candidates

  • Localized prostate cancer (no spread outside the prostate)
  • Cancer visible on mpMRI and confirmed by targeted biopsy
  • Intermediate-risk disease (Gleason 3+4 = 7, sometimes 4+3 = 7) is the sweet spot
  • Selected low-risk patients who do not want active surveillance
  • Men prioritizing preservation of urinary and sexual function
  • Recurrent cancer after radiation (salvage HIFU in selected cases)

May Not Be Ideal For

  • High-volume or multifocal cancer scattered across both lobes
  • High-risk disease (Gleason 8+) — typically needs whole-gland treatment
  • Very large prostate (>40–50 cc) — may require pre-treatment debulking
  • Heavy prostate calcifications blocking the ultrasound beam
  • Significant rectal disease or prior rectal surgery
  • Cancer outside the prostate (lymph nodes, bones)

HIFU vs. Surgery vs. Radiation

Feature HIFU (Focal) Robotic Prostatectomy Radiation
Incisions None 5–6 small None
Recovery ~1–2 weeks 3–6 weeks Variable; daily for 4–8 weeks
Catheter ~1–2 weeks ~1 week Usually none
Long-term incontinence Low (1–5%) 5–15% Low
Erectile dysfunction risk Lower (focal) Variable, often higher Develops gradually over years
Repeatable Yes No (only one prostate) Limited
Salvage options if recurrence All standard treatments remain available Salvage radiation, hormonal therapy Salvage surgery is challenging

HIFU is best understood as a "middle path" between active surveillance and whole-gland therapy. It treats known cancer while leaving the door open to all standard treatments later if needed.

What Are the Results?

HIFU has been studied in tens of thousands of patients worldwide over more than 25 years. Outcomes for properly selected patients are very good.

Outcome Result
Cancer-free rate in treated zone ~85–95% at 5 years
Freedom from radical treatment ~80–90% at 5 years
Continence preservation 95–99%
Erection preservation 70–85% (when nerves are not directly treated)
Need for re-treatment 10–20% over 5 years (HIFU repeat, surgery, or radiation)

Recovery

Day of Procedure

  • Most patients go home the same day
  • A Foley catheter is left in place for 1–2 weeks
  • Mild perineal soreness is normal

Week 1–2

  • Catheter removed at follow-up
  • Light blood-tinged urine for a few days is normal
  • Resume desk work within a few days; avoid heavy lifting for 2 weeks

Weeks 3–6

  • Resume exercise and sexual activity as comfort allows
  • Erections often improve over weeks to months
  • Begin scheduled PSA testing

Long-Term Surveillance

  • PSA every 3–6 months
  • Repeat MRI at ~6–12 months
  • Targeted biopsy at 12 months to confirm clearance
  • Continued long-term follow-up — recurrence elsewhere in the prostate is the most common pattern of failure and is treatable

Risks & Potential Side Effects

  • Urinary retention requiring catheter — common short-term, usually resolves
  • Urinary tract infection — uncommon
  • Erectile dysfunction — risk depends on treatment field; lower with truly focal HIFU
  • Mild stress urinary incontinence — uncommon, usually transient
  • Urethral stricture or bladder-neck contracture — small percentage; treatable
  • Recto-urethral fistula — rare but serious; very low rate in experienced hands
  • Cancer in untreated areas — found on follow-up biopsy in some patients; treatable

Frequently Asked Questions

Is HIFU FDA-approved?

Yes. HIFU is FDA-cleared for prostate tissue ablation. The use of HIFU for prostate cancer is supported by major urology guidelines as a focal therapy option in appropriately selected patients.

Will HIFU give me erectile dysfunction?

It depends on which part of the prostate is treated. When treatment can spare the neurovascular bundles, the majority of men retain their erections. We discuss the expected impact for your specific tumor and anatomy before treatment.

Can HIFU be repeated?

Yes. If a small area of cancer is found again, HIFU can often be repeated. All standard treatments — surgery and radiation — also remain available.

Will my PSA go to zero after HIFU?

No, because the rest of the prostate remains. PSA typically falls and stabilizes at a new lower baseline. Trends — not a single number — are what we follow.

How does HIFU compare to active surveillance?

For low-risk disease, active surveillance remains an excellent option. HIFU is most useful when biopsy and MRI show clearly localized intermediate-risk cancer — treating it now while preserving function rather than deferring.

Is HIFU covered by insurance?

HIFU is covered by Medicare and many private insurance plans. Coverage varies and our team will verify your specific policy and obtain prior authorization before treatment.

Treat the Cancer, Preserve the Man

If you have localized intermediate-risk prostate cancer and want to control it without sacrificing urinary continence and sexual function, HIFU may be the right next step. Our team is highly experienced with MRI-fusion targeted therapy and will help you decide between active surveillance, focal HIFU, and whole-gland treatments.

  • ✅ Incisionless, no-radiation focal therapy
  • ✅ Outpatient — typically home the same day
  • ✅ Highest rates of urinary and sexual function preservation
  • ✅ Repeatable; preserves all future treatment options
Schedule Your Consultation

Call 678-344-8900 to speak with our prostate-cancer team